Abstract Details
|
Matthew A. Tremblay, MD
(RWJ Barnabas Health)
PRESENTER |
Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Tremblay has received research support from Biogen Inc. Dr. Tremblay has received publishing royalties from a publication relating to health care. |
| Matthew J. Ashley, MD | No disclosure on file |
| Harry Vinters | No disclosure on file |
| Ming Guo, MD, PhD (UCLA School of Medicine) | No disclosure on file |
| Andrew McKeon, MD (Mayo Clinic) | The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |